Other

Granted (in shares)

Zoetis Granted (in shares) increased by 80606.2% to $129.13 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.6%, from $156.64 to $129.13.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 7, 2026

How to read this metric

Trends in share grants help investors model future share count dilution and assess the intensity of management's equity-based compensation.

Detailed definition

This metric represents the aggregate number of shares granted under specific share-based payment arrangements, often use...

Peer comparison

Standard disclosure for companies with active equity compensation programs.

Metric ID: other_share_based_compensation_arrangements_by_share_bas_099e66

Historical Data

7 periods
 Q1 '22Q1 '23Q2 '23Q1 '24Q1 '25Q2 '25Q1 '26
Value$201.30$162.07$0.05$196.14$156.64$0.16$129.13
QoQ Change-19.5%-100.0%>999%-20.1%-99.9%>999%
YoY Change-19.5%+21.0%-20.1%-17.6%
Range$0.05$201.30
CAGR-25.6%
Avg YoY Growth-9.0%
Median YoY Growth-18.5%

Frequently Asked Questions

What is Zoetis's granted (in shares)?
Zoetis (ZTS) reported granted (in shares) of $129.13 in Q1 2026.
How has Zoetis's granted (in shares) changed year-over-year?
Zoetis's granted (in shares) decreased by 17.6% year-over-year, from $156.64 to $129.13.
What does granted (in shares) mean?
The total number of shares issued or granted under specific equity compensation plans.